NEO
Neogenomics Inc
Price:  
16.04 
USD
Volume:  
477,869.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NEO WACC - Weighted Average Cost of Capital

The WACC of Neogenomics Inc (NEO) is 7.7%.

The Cost of Equity of Neogenomics Inc (NEO) is 8.60%.
The Cost of Debt of Neogenomics Inc (NEO) is 5.50%.

Range Selected
Cost of equity 7.40% - 9.80% 8.60%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 4.00% - 7.00% 5.50%
WACC 6.5% - 8.9% 7.7%
WACC

NEO WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.77 0.89
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.40% 9.80%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.26 0.26
Cost of debt 4.00% 7.00%
After-tax WACC 6.5% 8.9%
Selected WACC 7.7%